Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
USWM, LLC (dba US WorldMeds)
Pfizer
AstraZeneca
Pfizer
Dragonfly Therapeutics
Hoffmann-La Roche
ViroMissile, Inc.
Tizona Therapeutics, Inc
Adaptimmune
xCures
Daiichi Sankyo
Natera, Inc.
Second Life Therapeutics
Onchilles Pharma Inc
Elephas
Novartis
Elephas
Inhibrx Biosciences, Inc
TScan Therapeutics, Inc.
TScan Therapeutics, Inc.
Bolt Biotherapeutics, Inc.
Tempus AI
Massive Bio, Inc.
Actym Therapeutics, Inc.
Memgen, Inc.
Palleon Pharmaceuticals, Inc.
Sensei Biotherapeutics, Inc.
Incyte Corporation
MacroGenics
Delfi Diagnostics Inc.
Marengo Therapeutics, Inc.
Genentech, Inc.
DEKA Biosciences
Rapa Therapeutics LLC
Tempus AI
Revolution Medicines, Inc.
Labcorp Corporation of America Holdings, Inc
Checkpoint Therapeutics, Inc.
BioAtla, Inc.
Aminex Therapeutics, Inc.
Taproot Health
Inhibrx Biosciences, Inc
Novartis
Xencor, Inc.
iTeos Therapeutics
Innolake Biopharm
Presage Biosciences
Pfizer
Celldex Therapeutics